This paper is in the following e-collection/theme issue:

mHealth for Treatment Adherence (207) Mobile Health (mhealth) (1083) Mobile Health in Psychiatry (164) Psychotic Disorders (85)

Published on in Vol 5, No 2 (2017): February

Use of a Novel Artificial Intelligence Platform on Mobile Devices to Assess Dosing Compliance in a Phase 2 Clinical Trial in Subjects With Schizophrenia

Use of a Novel Artificial Intelligence Platform on Mobile Devices to Assess Dosing Compliance in a Phase 2 Clinical Trial in Subjects With Schizophrenia

Use of a Novel Artificial Intelligence Platform on Mobile Devices to Assess Dosing Compliance in a Phase 2 Clinical Trial in Subjects With Schizophrenia

Authors of this article:

Earle E Bain 1 Author Orcid Image ;   Laura Shafner 2 Author Orcid Image ;   David P Walling 3 Author Orcid Image ;   Ahmed A Othman 1 Author Orcid Image ;   Christy Chuang-Stein 4 Author Orcid Image ;   John Hinkle 5 Author Orcid Image ;   Adam Hanina 2 Author Orcid Image
Article Authors Cited by (12) Tweetations (22) Metrics

Journals

  1. Díaz-Martín A, Schmitz A, Yagüe Guillén M. Are Health e-Mavens the New Patient Influencers?. Frontiers in Psychology 2020;11 View
  2. Lavorgna L, Brigo F, Moccia M, Leocani L, Lanzillo R, Clerico M, Abbadessa G, Schmierer K, Solaro C, Prosperini L, Tedeschi G, Giovannoni G, Bonavita S. e-Health and multiple sclerosis: An update. Multiple Sclerosis Journal 2018;24(13):1657 View
  3. Farpour H, Hoveidaei A, Habibi L, Moosavi M, Farpour S. The impact of social media use on depression in multiple sclerosis patients. Acta Neurologica Belgica 2020;120(6):1405 View
  4. Tucker J, Day S, Tang W, Bayus B. Crowdsourcing in medical research: concepts and applications. PeerJ 2019;7:e6762 View
  5. Yeandle D, Rieckmann P, Giovannoni G, Alexandri N, Langdon D. Patient Power Revolution in Multiple Sclerosis: Navigating the New Frontier. Neurology and Therapy 2018;7(2):179 View
  6. Lavorgna L, Borriello G, Esposito S, Abbadessa G, Capuano R, De Giglio L, Logoteta A, Pozzilli C, Tedeschi G, Bonavita S. Impact of early diagnosis on clinical characteristics of an Italian sample of people with multiple sclerosis recruited online. Multiple Sclerosis and Related Disorders 2019;27:239 View
  7. Cárdenas-Robledo S, Navarro C, Guío-Sánchez C. Multiple sclerosis coverage in the written media of a low prevalence country. Multiple Sclerosis and Related Disorders 2020;44:102266 View
  8. Tulloch J, Vivancos R, Christley R, Radford A, Warner J. Mapping tweets to a known disease epidemiology; a case study of Lyme disease in the United Kingdom and Republic of Ireland. Journal of Biomedical Informatics: X 2019;4:100060 View
  9. Brigo F, Lattanzi S, Giussani G, Tassi L, Pietrafusa N, Galimberti C, Bragazzi N, Mecarelli O. A cross-sectional survey among physicians on internet use for epilepsy-related information. Epilepsy Research 2020;165:106393 View
  10. Rahn A, Solari A, Beckerman H, Nicholas R, Wilkie D, Heesen C, Giordano A. “I Will Respect the Autonomy of My Patient”. International Journal of MS Care 2020;22(6):285 View
  11. Martini M, Bragazzi N. Googling for Neurological Disorders: From Seeking Health-Related Information to Patient Empowerment, Advocacy, and Open, Public Self-Disclosure in the Neurology 2.0 Era. Journal of Medical Internet Research 2021;23(3):e13999 View
  12. Lavorgna L, Brigo F, Esposito S, Abbadessa G, Sparaco M, Lanzillo R, Moccia M, Inglese M, Bonfanti L, Trojsi F, Spina E, Russo A, De Micco P, Clerico M, Tedeschi G, Bonavita S. Public Engagement and Neurology: An Update. Brain Sciences 2021;11(4):429 View